Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?

Kumarasamy, N.; Patel, Atul; Pujari, Sanjay
December 2011
Indian Journal of Medical Research;Dec2011, Vol. 134 Issue 6, p787
Academic Journal
With the rapid scale up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy -- antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.


Related Articles

  • Cohort Profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). May, Margaret T; Ingle, Suzanne M; Costagliola, Dominique; Justice, Amy C; de Wolf, Frank; Cavassini, Matthias; D’Arminio Monforte, Antonella; Casabona, Jordi; Hogg, Robert S; Mocroft, Amanda; Lampe, Fiona C; Dabis, François; Fätkenheuer, Gerd; Sterling, Timothy R; del Amo, Julia; Gill, M John; Crane, Heidi M; Saag, Michael S; Guest, Jodie; Brodt, Hans-Reinhard // International Journal of Epidemiology;Jun2014, Vol. 43 Issue 3, p691 

    The advent of effective combination antiretroviral therapy (ART) in 1996 resulted in fewer patients experiencing clinical events, so that some prognostic analyses of individual cohort studies of human immunodeficiency virus-infected individuals had low statistical power. Because of this, the...

  • A Multicenter Observational Study of the Potential Benefits of Initiating Combination Antiretroviral Therapy during Acute HIV Infection. Hecht, Frederick M.; Lei Wang; Collier, Ann; Little, Susan; Markowitz, Martin; Margolick, Joseph; Kilby, J. Michael; Daar, Eric; Conway, Brian; Holte, Sarah // Journal of Infectious Diseases;9/15/2006, Vol. 194 Issue 6, p725 

    Objective. Uncontrolled studies have suggested a benefit, after treatment discontinuation, of initiating highly active antiretroviral therapy (HAART) during primary human immunodeficiency virus (HIV) infection. We assessed whether initiation of HAART within 2 weeks of (acute treatment) or...

  • HIV in pregnancy: evolution of clinical practice in the UK. Foster, C. J.; Lyall, E. G. H. // International Journal of STD & AIDS;Oct2006, Vol. 17 Issue 10, p660 

    Prior to the introduction of interventions reducing mother-to-child transmission of HIV-1 natural history data reports vertical transmission rates in the order of 25%. The risk of transmission from mother-to-child has been associated with advanced maternal HIV disease, maternal plasma HIV viral...

  • Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia. Geda, Nuguse; Beyene, Tafese; Dabsu, Regea; Mengist, Hylemariam Mihiretie // PLoS ONE;12/5/2019, Vol. 14 Issue 12, p1 

    Background: Cryptococcosis is a global public health important infectious disease. HIV infection is the main risk factor estimated to account for 95% of cases in the middle- and low-income countries and 80% of the cases in high-income countries. Objective: The main aim of the study was to...

  • Lower CD4 gains on antiretroviral therapy make AIDS or death more likely.  // HIV Treatment ALERTS!;Apr2010, p30 

    The article presents a study on the effect of slow CD4 gains after viral load in blood was reduced to below 50 copies through antiretroviral therapy. It states that 121 gay men with or without HIV infection from four U.S. cities including Baltimore, Chicago, and Los Angeles were the subjects of...

  • Steps on the Critical Path: Arresting HIV/AIDS in Developing Countries. Gerberding, Julie // PLoS Medicine;Oct2004, Vol. 1 Issue 1, p014 

    Focuses on HIV/AIDS epidemic in developing countries. Information on the U.S. Centers for Disease Control and Prevention program in Uganda; Administration of antiretroviral drugs to HIV infected individuals in the region; Discussion on funding for AIDS intervention programs in Africa.

  • '3 by 5' makes progress but falls short. Roehr, Bob // Bay Area Reporter;7/7/2005, Vol. 35 Issue 27, p13 

    Reports on the possibility that the goal of the "3 by 5," program aimed at providing antiretroviral therapy to people living with HIV/AIDS in developing countries by the end of 2005 would not be met. Highlights of an interim report by the World Health Organization and UN-AIDS, released on June...

  • Initiation of Regular Marijuana Use Among a Cohort of Women Infected with or at Risk for HIV in the Women's Interagency HIV Study (WIHS). Kuo, Wen-Hung; Wilson, Tracey E.; Weber, Kathleen M.; Madhava, Valsa; Richardson, Jean; Delapenha, Robert; Jarlais, Don Des // AIDS Patient Care & STDs;Dec2004, Vol. 18 Issue 12, p702 

    Our study sought to determine the incidence of weekly marijuana use among HIV-infectedand uninfected women, to identify correlates of weekly marijuana use, and to test its associationwith stage of HIV disease and type of HIV treatment received. A total of 2059 HIV-positiveand 569 HIV-negative...

  • A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model. Shytaj, Iart Luca; Norelli, Sandro; Chirullo, Barbara; Della Corte, Alessandro; Collins, Matt; Yalley.-Ogunro, Jake; Greenhouse, Jack; Iraci, Nunzio; Acosta, Edward P.; Barreca, Maria Letizia; Lewis, Mark G.; Savarino, Andrea // PLoS Pathogens;Jun2012, Vol. 8 Issue 6, Special section p1 

    Stably suppressed viremia during ART is essential for establishing reliable simian models for HIV/AIDS. We tested the efficacy of a multidrug ART (highly intensified ART) in a wide range of viremic conditions (10³ -107 viral RNA copies/mL) in SIVmac251-infected rhesus macaques, and its impact...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics